Previous 10 | Next 10 |
Thomson Reuters ONE news releases related Thomson Reuters One news releases and Thomson Reuters One press releases from 02/27/20 07:29:25 on US and Canada...
VANCOUVER, British Columbia, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V/ASX: EMN) (the " Company " or " EMN ") is pleased to announce that shareholders have voted in favor of all matters of business brought before them at the Company's Annual General & Special Meeting of ...
Broad collaboration for gene regulation therapies in neurology, initially focused on development of ST-501 for tauopathies including Alzheimer’s disease, ST-502 for synucleinopathies including Parkinson’s disease, and a neuromuscular target, with exclusive rights for nine additi...
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the Cowen and Company 4...
~ Up to Two Years of Follow-up in Large Transgenic Huntington’s Disease Model Demonstrates Stable mHTT Protein Lowering ~ ~ Novel Preclinical Data Demonstrates Successful Lowering of Pathogenic Exon 1 Fragment ~ ~ Additional Data Demonstrates the Potential of MRS as Imaging Bi...
February 27, 2020 Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the European Society of Radiology (ESR), today announced a collaboration to host an Ultrasound Academy at the European...
LYON, France and CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Gil Bey...
Vaccine candidate derived from coronavirus spike (S) protein Matrix-M™ adjuvant expected to boost immune responses Phase 1 clinical trial planned for late spring GAITHERSBURG, Md., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company d...
Demonstration plant commissioned and technology confirmed SAINT-MICHEL-DES-SAINTS, Quebec, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Nouveau Monde Graphite Inc. (“Nouveau Monde” or “NMG”), ( TSX.V: NOU ; OTCQX: NMGRF ; Frankfurt: NM9 ) has successfully commi...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO U.S. PERSONS, OR IN CANADA, AUSTRALIA, JAPAN, THE RUSSIAN FEDERATION OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. MOSCOW and...
GAITHERSBURG, Md., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced a publication in Vaccines describing the immunogenic potential of NanoFlu™, Novava...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
16.01%Change Percent:
Nano One Materials Corp Company Name:
NNOMF Stock Symbol:
OTCMKTS Market:
nanoone.ca Website: